Suven Pharmaceuticals Ltd (SPL) demerged away from Suven Life Sciences in 2018 and was listed on 9th March 2020. Suven Pharmaceuticals is an integrated CDMO player with strong capabilities in process research, custom synthesis, formulation development analytical and services.
Make Informed Decisions about Investing in Stocks
STOCKDIGEST 